MMCTS
HOME HELP FEEDBACK SUBSCRIPTIONS SEARCH

MMCTS (March 24, 2005). doi:10.1510/mmcts.2004.000521
Copyright © 2005 European Association for Cardio-thoracic Surgery


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Videos
Right arrow Alert me when this content is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this publication
Right arrow Alert me when new content is published
Right arrow Download to citation manager
Right arrow Alert me when related articles are published
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Calafiore, A. M.
Right arrow Articles by Bivona, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Calafiore, A. M.
Right arrow Articles by Bivona, A.
Related Collections
Right arrow Mechanical complications of ischemic heart disease
 

Procedure


Mitral valve repair in ischemic mitral regurgitation

Antonio Maria Calafiorea,*, Michele Di Maurob, Marco Continib, Luca Welterta and Antonio Bivonab

a Division of Cardiac Surgery, University Hospital, "S. Giovanni Battista", c.so Bramante 86, Turin, Italy
b Division of Cardiac Surgery, "G D'Annunzio" University, Chieti, Italy

* Corresponding author: * Tel.: +39 011 6335514; Fax: +39 011 6336130. E-mail: calafiore{at}unich.it

Ischemic mitral regurgitation (IMR) is a common complication after acute myocardial infarction due to annulus dilatation and papillary muscles displacement. In our opinion 3/4 and 4/4 IMR have always to be indicated for MV surgery. In presence of low EF and dilated LV, moderate (2/4) IMR has to be corrected. The end-systolic distance between the coaptation point of mitral leaflets and the plane of mitral valve annulus is the key point to decide repair (≤10 mm) or replacement (>10 mm). MV annuloplasty has always been addressed to the posterior annulus, whose size can be easily reduced. A specially designed 40 mm long ring has been used to achieve a posterior overreductive annuloplasty. For MV repair thirty-day mortality was 2.4%. Five-year survival and the possibility of being alive and in NYHA class I-II were 75.6±4.7 and 59.8±5.4, respectively. After a mean of 38±35 months, the NYHA class decreases from 3.2±0.5 to 2.1±0.6 (P<0.001). Most patients (77.4%) have an improvement of its own functional class. MR decreases from 3.2±0.8 to 1.2±1.1 (P<0.001). 97.5% of the survivors have MR equal to or less than moderate.

Key Words: mitral valve • ischemic mitral regurgitation • mitral valve annulopasty







HOME HELP FEEDBACK SUBSCRIPTIONS SEARCH
Copyright © 2005 by The European Association for Cardio-thoracic Surgery.